10.1186/2194-0517-2-1

Polystyrene microsphere and 5-fluorouracil release from custom-designed wound dressing films

Show Details XML HTML PDF
  • Maryam Mobed-Miremadi*1,
  • Raki Komarla Nagendra2,
  • Sujana Lakshmi Ramachandruni2,
  • Jason James Rook3,
  • Mallika Keralapura4,
  • Michel Goedert1,
  1. Department of Biomedical, Chemical and Materials Engineering, San Jose State University, San Jose, CA, 95192-0082, US
  2. MSE Biomedical Devices Concentration, San Jose State University, San Jose, CA, US
  3. MSE Biomedical Engineering, San Jose State University, San Jose, CA, US
  4. Department of Electrical Engineering, San Jose State University, San Jose, CA, US
Cover Image

Published in Issue 2013-01-24

How to Cite

Mobed-Miremadi, M., Nagendra, R. K., Ramachandruni, S. L., Rook, J. J., Keralapura, M., & Goedert, M. (2013). Polystyrene microsphere and 5-fluorouracil release from custom-designed wound dressing films. Progress in Biomaterials, 2(1 (December 2013). https://doi.org/10.1186/2194-0517-2-1
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract Custom-designed wound dressing films of chitosan and alginate have been prepared by a casting/solvent evaporation method for hydrophobic therapeutic agent encapsulation. In this parametric study, the propylene glycol (PG) and calcium chloride (CaCl 2 ) concentrations were varied for chitosan and alginate films, respectively. Mechanical and chemical inter-related responses under observations included thickness ( th ), elasticity (E), tensile strength ( TS ), sorption ability (S%) and kinetics of in-vitro drug release, specifically in terms of membrane time to burst ( t B ) and duration of release ( t R ). As shown by results of a one tailed t-test significance testing at the 95% confidence interval (α = 0.05), alginate films were significantly more elastic (p = 0.003), thinner (p = 0.004) and more susceptible to osmotic burst (p = 0.011) and characterized by a longer duration of release (p = 0.03). Meanwhile chitosan films exhibited superior moisture permeability (p = 0.006) and sorption characteristics (p = 0.001), indicative of higher hydrophilicity. There were no significant differences in tensile strength (p = 0.324) for alginate and chitosan-based formulations. Preliminary testing was conducted using 0.71 μm in diameter microspheres for modeling film dissolution into Lactated Ringer’s solution. Experimental release profiles were modeled for each film from which the average release from alginate films ( M AGCa   = 81% ) was estimated to be twice the percentage associated with chitosan films ( M CD   = 42%). The film comprised of 2.5% (w/v) medium MW chitosan/dextran 70 kDa (5:1) was selected for studying the release of 5-Fluorouracil (5-FU) as a model hydrophobic drug. Diffusion coupled with film disintegration is immediate ( t B  = 0) in case of encapsulated 5-FU as compared to the control film encapsulating microspheres characterized by t B  = 70 min ± 7 min. This shift in release profile and the ability to modulate the timing of membrane burst can be attributed to the approximate ratio (1: 505) in molecular size between drug and microsphere. This hypothesis has been validated by the film pore size measured to be 430 nm ± 88 nm using atomic force microscopy.

Keywords

  • Chitosan,
  • Alginate,
  • Microsphere,
  • 5-FU,
  • Pore size,
  • Atomic force microscopy,
  • Release modeling
HTML PDF

References

  1. Adusumilli and Bolton (1991) Evaluation of chitosan citrate complexes as matrices for controlled release formulations using a full 32 factorial design (pp. 1931-1945) https://doi.org/10.3109/03639049109048059
  2. Ahmed et al. (2012) Dual-tuned drug release by nanofibrous scaffolds of chitosan and mesoporous silica microspheres (pp. 25027-25035) https://doi.org/10.1039/c2jm35569h
  3. Akbuga and Bergisadi (1996) 5-Fluorouracil loaded chitosan microspheres: Preparation and release characteristics (pp. 161-168) https://doi.org/10.3109/02652049609052904
  4. Asthana et al. (2012) Rapid and cost-effective fabrication of selectively permeable calcium-alginate microfluidic device using “modified” embedded template method 6(1) (pp. 012821-0128219) https://doi.org/10.1063/1.3672189
  5. Ayogi et al. (2007) Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds 330(1–2) (pp. 138-145) https://doi.org/10.1016/j.ijpharm.2006.09.016
  6. Bhuvaneshwari et al. (2011) Development and characterization of chitosan films 1(2) (pp. 292-299)
  7. Burkatovskaya et al. (2008) Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice 16(3) (pp. 425-431) https://doi.org/10.1111/j.1524-475X.2008.00382.x
  8. Callister and Rethwisch (2010) John Wiley & Sons
  9. Casettaria et al. (2012) PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications 37(5) (pp. 659-685) https://doi.org/10.1016/j.progpolymsci.2011.10.001
  10. Chandrashekar and Prasanth (2008) Clinical evaluation of 5-fluorouracil form transdermal patches on EAC and DLA cell-induced tumors in mice (pp. 437-440)
  11. Chilcott et al. (2005) Inter- and intra-laboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials 94(3) (pp. 632-638) https://doi.org/10.1002/jps.20229
  12. Dash et al. (2011) Chitosan – a versatile semi-synthetic polymer in biomedical applications 36(8) (pp. 981-1014) https://doi.org/10.1016/j.progpolymsci.2011.02.001
  13. Dhoot and Wheatley (2003) Microencapsulated liposomes in controlled drug delivery: strategies to modulate drug release and eliminate the burst effect 92(3) (pp. 679-689) https://doi.org/10.1002/jps.19104
  14. Diasio and Harris (1989) Clinical pharmacology of 5-fluorouracil (pp. 215-237) https://doi.org/10.2165/00003088-198916040-00002
  15. Doulabia et al. (2013) Chitosan/polyethylene glycol fumarate blend film: Physical and antibacterial properties (pp. 48-56) https://doi.org/10.1016/j.carbpol.2012.09.002
  16. Unknown (2000)
  17. Dureja et al. (2001) Simulation of skin permeability in chitosan membranes (pp. 193-198) https://doi.org/10.1016/S0378-5173(00)00666-9
  18. Unknown (2012)
  19. Fournier (2011) Taylor & Francis
  20. Franz (1978) The finite dose technique as a valid in vitro model for the study of percutaneous absorption (pp. 58-612) https://doi.org/10.1159/000401276
  21. Gaserod et al. (1999) Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability 20(8) (pp. 773-783) https://doi.org/10.1016/S0142-9612(98)00230-0
  22. Gay et al. (1983) Defense Technical Information Center
  23. Giannola et al. (2010) 5-Fluorouracil buccal tablets for locoregional chemotherapy of oral squamous cell carcinoma: formulation, drug release and histological effects on reconstituted human oral epithelium and porcine buccal mucosa 7(2) (pp. 109-117) https://doi.org/10.2174/156720110791011792
  24. Hu et al. (2007) Self-assembly and fractal feature of chitosan and its conjugate with metal ions: Cu (II) / Ag (I) (pp. 1-12) https://doi.org/10.3390/i8010001
  25. Jana et al. (2012) High-strength pristine porous chitosan scaffolds for tissue engineering (pp. 6291-6299) https://doi.org/10.1039/c2jm16676c
  26. Karakecili et al. (2007) Surface characteristics of ionically crosslinked chitosan membranes 106(6) (pp. 3884-3888) https://doi.org/10.1002/app.26920
  27. Khan et al. (2000) Mechanical, bio-adhesive strength and biological evaluations of chitosan films for wound dressing 3(3) (pp. 303-311)
  28. Li et al. (2011) Production and characterization of thick, thin and ultra-thin chitosan/PEOfilm 83(2) (pp. 375-382) https://doi.org/10.1016/j.carbpol.2010.07.064
  29. Li et al. (2012) A viscoelastic chitosan-modified three-dimenasional porous poly (L-lactide-co-ε-caprolactone) scafold for cartilage tissue engineering 23(1–4) (pp. 405-424) https://doi.org/10.1163/092050610X551970
  30. Loven et al. (2002) Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis 24(6) (pp. 990-1000) https://doi.org/10.1016/S0149-2918(02)80012-1
  31. Madsen et al. (2011) Short cellulosic fiber/starch acetate composites micromechanical modeling of Young’s modulus 45(20) (pp. 2119-21327) https://doi.org/10.1177/0021998311401063
  32. Meng et al. (2010) Chitosan and alginate polyelectrolyte complex membranes and their properties for wound dressing application 21(5) (pp. 1751-1759) https://doi.org/10.1007/s10856-010-3996-6
  33. Mitchell and Blanshard (1974) Viscoelastic behaviour of alginate gels
  34. Mobed and Chang (1998) Comparison of polymerically-stabilized PEG liposomes and physically-adsorbed carboxymethyl and carboxymethyl/glycolchitin liposomes for biological applications (pp. 1167-1177) https://doi.org/10.1016/S0142-9612(98)00004-0
  35. Moresi et al. (2001) Viscoelastic properties of alginate gels by oscillatory dynamic tests 32(5–6) (pp. 375-396) https://doi.org/10.1111/j.1745-4603.2001.tb01243.x
  36. Murakami et al. (2010) Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings (pp. 83-90) https://doi.org/10.1016/j.biomaterials.2009.09.031
  37. Ng et al. (2010) Validation of a static Franz diffusion cell system for in vitro permeation studies 11(3) (pp. 1432-1441) https://doi.org/10.1208/s12249-010-9522-9
  38. Ramadas et al. (2000) Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats 17(4) (pp. 405-411) https://doi.org/10.1080/026520400405660
  39. Rhim (2004) Physical and mechanical properties of water resistant sodium alginate films (pp. 323-330)
  40. Rook et al. (2012) Characterization of fluorouracil diffusion from chitosan films
  41. Saterbak et al. (2007) Pearson/Prentice Hall
  42. Sezer et al. (2007) Chitosan film containing fucoidan as a wound dressing for dermal burn healing: preparation and in vitro/in vivo evaluation 8(2) (pp. E94-E101) https://doi.org/10.1208/pt0802039
  43. Shabbear et al. (2012) Formulation and evaluation of chitosan sodium alginate microcapsules of 5-fluorouracil for colorectal cancer 2(1) (pp. 7-19)
  44. Shon et al. (2007) Viscoelastic sol–gel state of the chitosan and alginate solution mixture 104(3) (pp. 1408-1414) https://doi.org/10.1002/app.24553
  45. Shuler and Kargi (2010) Prentice Hall
  46. Silver et al. (2007) Viscoelastic properties of human skin and processed dermis (pp. 18-23)
  47. Simpliciano and Asi (2012) Pore size determination and validation using AFM and spectrophotometry
  48. Smith and Haigh (1992) In vitro diffusion cell design and validation. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation 4(3) (pp. 171-178)
  49. Storz et al. (2010) Viscoelastic properties of ultra-high viscosity alginates 49(2) (pp. 155-167) https://doi.org/10.1007/s00397-009-0400-x
  50. Suheyla (1997) Chitosan: Properties, preparation and application to micro particulate system (pp. 689-711) https://doi.org/10.3109/02652049709006820
  51. Tada et al. (2010) Chitosan film containing poly(D, L-lactic-co-glycolic acid) nanoparticles: A platform for localized dual drug release 27(8) (pp. 1738-1745) https://doi.org/10.1007/s11095-010-0176-9
  52. Tiwary and Rana (2010) Cross-linked chitosan films: effect of cross-linking density on swelling parameters 23(4) (pp. 443-448)
  53. Torres et al. (2006) Viscous and viscoelastic properties of chitosan solutions and gels 9(2) (pp. 101-108)
  54. US National Library of Medicine Database 2012.
  55. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac
  56. . Accessed on 27 December 2012
  57. van de Hulst (1981) Dover
  58. Wang et al. (2001) Chitosanalginate-CaCl2 system for membrane coat application (pp. 1134-1142) https://doi.org/10.1002/jps.1067
  59. Wang et al. (2003) Induction of apoptosis and cell cycle arrest by polyvinylpyrrolidone K-30 and protective effect of α-tocopherol 308(4) (pp. 878-884) https://doi.org/10.1016/S0006-291X(03)01485-2
  60. Wittaya-arrekul and Prasharn (2006) Development and in vitro evaluation of chitosan-polysaccharides composite wound dressings (pp. 123-128) https://doi.org/10.1016/j.ijpharm.2006.01.027
  61. Woolfson et al. (1995) Abioadhesive patch cervical drug delivery system for administration of 5-fluorouracil to cervical tissue (pp. 676-681)
  62. Zhao et al. (2009) Effect of organic and inorganic acids on chitosan/glycerophosphate thermosensitive hydrogel 50(1) (pp. 111-118) https://doi.org/10.1007/s10971-008-1891-0
  63. Zheng et al. (2009) The behavior of MC3T3-E1 cells on chitosan/poly-L-lysine composite films: Effect of nanotopography, surface chemistry, and wettability 89(2) (pp. 453-465) https://doi.org/10.1002/jbm.a.31979